Baudax Bio, Inc.
Baudax Bio, Inc., a biopharmaceutical company headquartered in the United States, focuses on developing innovative therapeutics for patients in need. Founded in 2018, Baudax Bio has quickly established itself in the industry, particularly in the areas of pain management and anaesthesia. The company’s flagship product, Exparel, is a unique liposomal formulation of bupivacaine, designed to provide prolonged analgesia with a single administration. This innovative approach sets Baudax Bio apart in a competitive market, addressing the growing demand for effective pain relief solutions. With a commitment to advancing patient care, Baudax Bio has achieved significant milestones, positioning itself as a key player in the biopharmaceutical landscape. The company continues to explore new avenues for growth, aiming to enhance the quality of life for patients worldwide.
DitchCarbon Score
How does Baudax Bio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Baudax Bio, Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Baudax Bio, Inc.'s reported carbon emissions
Baudax Bio, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is unclear how the company is addressing its carbon footprint or what commitments it has made towards climate action. In the absence of concrete data, it is essential to monitor the company's future disclosures for any developments in their climate initiatives or emissions reporting.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Baudax Bio, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
